Guidance
Adjusted Fiscal 2025 Fiscal 2024 Fiscal 2025 EBITDA Midpoint Actual Cash flow from operating Adjusted activities $70-$90 EBITDA $387 $284 Pre-merger cash flow from operating activities GLT Pro (7) 90 forma 8 99 Additions to Foreign PPE (net) (85) currency (15) ------------ ----------- ----------- ------------ ------------ Post-merger Full Year adjusted Comparable free cash Adjusted flow (1) $75 - $95 EBITDA $395 $368 % vs. prior year comparable 7%
(1) Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States ("GAAP"). These non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Comparable basis measures exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative measures. Management believes that adjusted EBITDA and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of items that, in management's view, do not reflect our core operating performance. We define "Post-merger free cash flow" as cash flow from operating activities, less pre-merger free cash flow, less net additions to property, plant, and equipment. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company's liquidity. We also believe post-merger free cash flow which is useful to an investor in evaluating our liquidity, as it can assist in assessing a company's ability to fund its growth through its generation of cash because pre-merger cash flow is not indicative of our current structure and operations.
We also use Adjusted EBITDA and comparable basis measures, among other measures, to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA is a measure widely used by investors, securities analysts, and other interested parties in our industry to measure a company's performance. We also believe these measures are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods.
(2) Includes $17 million of transaction compensation as well as restructuring, business optimization and other charges
(3) Consists of estimated parent-allocated charges for the period prior to merger which is required by GAAP as part of the carve-out financial statement process.
(4) Includes a $12 million inventory step-up charge related to GLT merger in current period and other non-cash charges.
(5) Includes stock compensation expense
(6) The prior year comparable basis change excludes the impacts of foreign currency and acquisition/mergers.
(7) Pre-merger cash flow includes cash from operations prior to the merger and cash payments burdened by the transaction.
IR Contact Information
Robert Weilminster
EVP, Investor Relations
IR@magnera.com
(END) Dow Jones Newswires
February 06, 2025 06:30 ET (11:30 GMT)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.